About Ironleaf Capital LP
Ironleaf Capital is a private equity firm that specializes in healthcare technology. It seeks to partner with founders and management teams to build market-leading tech-enabled businesses that improve the efficiency, cost, and quality of healthcare. The firm launched in November 2025, backed by New Catalyst Strategic Partners. That partnership gave Ironleaf both capital to fund its launch and operational value-creation resources. Ironleaf registered with the SEC as an investment adviser in February 2026. Its first fund, Ironleaf Capital Fund I-A LP, has reported about 60.1 M of capital raised in SEC filings. Ironleaf makes mainly control investments in companies with Target EBITDA: ~$5–20M, led by growth-minded founders and operators. It invests exclusively in healthcare IT and tech-enabled healthcare solutions, using a theme-based, thesis-driven process to find sub-sectors with durable growth trends and innovative companies that use technology to solve industry pain points. Its investment activities include buyouts, founder and family transitions, recapitalizations, platform acquisitions and add-on acquisitions. Ironleaf creates value through its proprietary SCALE Method™ framework. It agrees a shared vision with management, then guides, resources, empowers, advocates for and supports teams as they carry it out, drawing on a team of experienced investors, former operators and healthcare specialists. Ironleaf Capital was founded in 2025 by T.J. Rose, its Managing Partner, a former Partner at Veritas Capital and Abry Partners. It is headquartered in New York, New York, United States.